While the test focuses on peptide pathway variants (GLP1R, GIPR, FTO, MC4R), these genetic factors influence broader metabolic health and immune function that can affect your response to targeted wellness interventions
Do you want FDA approval
GHRP-2 stimulates growth hormone release, which promotes lipolysis (fat breakdown) However, GHRP-2 increases food intake by 35.9% in healthy individuals The appetite increase is dose-dependent (10-34% increase depending on dose) Fat loss requires strict dietary control to counteract increased hunger GHRP-2 works best as part of a comprehensive body recomposition strategy , not as a standalone fat loss agent Effects are similar in both lean and obese individuals The research is clear: GHRP-2, like its natural counterpart ghrelin, acts as a potent appetite stimulant

Medications Certain prescription drugs can alter hormone balance and trigger gynecomastia, including: Anabolic steroids and androgen blockers used for prostate cancer treatment Antibiotics like metronidazole and ketoconazole Anti-ulcer drugs like cimetidine Anti-anxiety medications, such as diazepam (Valium) Underlying Conditions Some health conditions affect hormone balance and metabolism, increasing gynecomastia risk: Liver or kidney failure Low testosterone Testicular tumors Hyperthyroidism Tumors producing hCG hormone Genetic disorders like Klinefelter syndrome Substance Use Heavy alcohol and marijuana use may alter hormone levels and contribute to gynecomastia in some cases
Reference: Important note though
doi:10.1002/1098-2396(20010101)39:1 3.0.CO;2-3